Background illustration for clinical trials search

Paid Clinical Trials El Paso

Discover 885 paid clinical trials in El Paso, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

for
Myelofibrosis
Location: Denver CO, Salt Lake City UT, Tucson AZ, Minneapolis MN,
Sponsor: Sumitomo Pharma America, Inc.

Sex: All

Age: 18+

Code: NCT04176198

Phase 1, Phase 2, Recruiting

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

for
Multiple Myeloma
Location: Denver CO, Aurora CO, Phoenix AZ, San Diego CA,
Sponsor: European Myeloma Network B.V.

Sex: All

Age: 18+

Code: NCT05243797

Phase 3, Recruiting

Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease

for
cGVHD
Location: Denver CO, Aurora CO, Salt Lake City UT, Fairway KS,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT05919511

Recruiting

A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment

for
Multiple Myeloma
Location: Denver CO, Orange CA, Los Angeles CA, Houston TX,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05828511

Phase 1, Phase 2, Recruiting

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

for
Hematologic Malignancies, Waldenstroms Macroglobulinaemia,
Location: Denver CO, Springdale AR, Dallas TX, Spokane WA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT04728893

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)

for
B-cell Acute Lymphoblastic Leukemia
Location: Denver CO, Aurora CO, Austin TX, San Antonio TX,
Sponsor: Cellectis S.A.

Sex: All

Age: 15 - 50

Code: NCT04150497

Phase 1, Phase 2, Recruiting

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

for
AML, AML With Mutated NPM1, Hematologic Malignancy, KMT2Ar,
Location: Denver CO, Omaha NE, Oklahoma City OK, Kansas City KS,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06001788

Phase 1, Recruiting

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

for
Metastatic Uveal Melanoma, Cutaneous Melanoma,
Location: Denver CO, Los Angeles CA, Houston TX, Nashville TN,
Sponsor: IDEAYA Biosciences

Sex: All

Age: 18+

Code: NCT03947385

Phase 1, Phase 2, Recruiting

Study of APVO436 in Patients With AML or MDS

for
AML, MDS
Location: Denver CO, Salt Lake City UT, Westwood KS, Dallas TX,
Sponsor: Aptevo Research and Development LLC

Sex: All

Age: 18+

Code: NCT03647800

Phase 1, Recruiting

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

for
Neoplasms
Location: Denver CO, Aurora CO, Salt Lake City UT, Wichita KS,
Sponsor: Celgene

Sex: All

Age: 0+

Code: NCT03435796

Phase 2, Phase 3, Recruiting

APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML

for
Acute Myeloid Leukemia (AML)
Location: Denver CO, Fairway KS, Dallas TX, Houston TX,
Sponsor: Aptevo Therapeutics

Sex: All

Age: 18+

Code: NCT06634394

Phase 1, Recruiting

DALY II USA/ MB-CART2019.1 for DLBCL

for
Refractory Diffuse Large B Cell Lymphoma (DLBCL),
Location: Denver CO, Westwood KS, Phoenix AZ, Gilbert AZ,
Sponsor: Miltenyi Biomedicine GmbH

Sex: All

Age: 18+

Code: NCT04792489

Phase 2, Recruiting

CER-1236 in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myelofibrosis (MF)

for
AML, Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia
Location: Denver CO, Houston TX, Sacramento CA, Nashville TN,
Sponsor: CERo Therapeutics Holdings, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06834282

Phase 1, Recruiting

CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial

for
Trauma, Hemorrhage
Location: Denver CO, Aurora CO, Albuquerque NM, Lubbock TX,
Sponsor: Jason Sperry

Sex: All

Age: 18 - 70+

Code: NCT05958342

Phase 2, Recruiting

A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors

for
Platinum-resistant Ovarian Cancer, Testicular Cancer,
Location: Denver CO, Omaha NE, Dallas TX, Little Rock AR,
Sponsor: Context Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT06515613

Phase 1, Recruiting

Study of New Catheter & Pressure Monitor System to Help Prevent Compartment Syndrome From Developing in the Injured Leg

for
Compartment Syndrome
Location: Denver CO, Minneapolis MN, St. Louis MO,
Sponsor: Twin Star Medical, Inc.

Sex: All

Age: 18 - 60

Code: NCT00681616

Recruiting

Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

for
Hematopoietic Cell Transplantation Recipient, Leukemia,
Location: Denver CO, Aurora CO, Albuquerque NM, Salt Lake City UT,
Sponsor: Children's Oncology Group

Sex: All

Age: 0+

Code: NCT00736749

Recruiting

QUELIMMUNE (SCD-PED) PediAtric SurVeillance REgistry

for
Acute Kidney Injury, Acute Kidney Injury Due to Sepsis
Location: Denver CO, Fort Worth TX, Dallas TX, Houston TX,
Sponsor: SeaStar Medical

Sex: All

Age: 0 - 22

Code: NCT06517810

Recruiting

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

for
Stage I Mixed Cell Type Kidney Wilms Tumor,
Location: Denver CO, Aurora CO, Albuquerque NM, Salt Lake City UT,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 30

Code: NCT06401330

Phase 3, Recruiting

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

for
Rhabdomyosarcoma
Location: Denver CO, Aurora CO, Salt Lake City UT, Wichita KS,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 50

Code: NCT07466316

Phase 3, Recruiting